Yizhi Liu

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2019, Front. Oncol..

The pathological significance of abnormal RON and PD-L1 expression in colorectal cancer

Zhigang Wu, Danrong Shi, Ming-Hai Wang, 2020 .

Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer

Zhigang Wu, Danrong Shi, Ming-Hai Wang, 2020, World journal of gastrointestinal oncology.

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2019, Journal of Immunotherapy for Cancer.

The MSP‐RON pathway regulates liver fibrosis through transforming growth factor beta‐dependent epithelial–mesenchymal transition

Lanjuan Li, Tianhao Weng, Zhigang Wu, 2021, Liver international : official journal of the International Association for the Study of the Liver.